← Leaderboards
Janice Endsley
University Of Texas Med Br Galveston
$1,164,080
Attributed
$1,164,080
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $680K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,164,080 · 1
By mechanism
N01$1,164,080 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Med Br Galveston
Same institution · by research overlap
- Alexander Bukreyev$20,278,136
- Janice J Endsley$8,720,531
- Pedro Fernandez-Funez$3,063,023
- Timothy Reistetter$2,669,508
- Mark Endsley$262,826
Others in their field
Other Emerging Leaders on “Acquired Immunodeficiency Syndrome”
- Kimberly Smith · Ppd Development Lp$122,008,792
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$72,037,072
- Leonard Freedman · Leidos Biomedical Research, Inc.$67,132,816
- Bambra Strokes · Ppd Development Lp$65,000,267
- Julie Ake · National Institute Of Allergy And Infectious Diseases$52,642,120
- Carina Remgsamai-Nhe · Fisher Bioservices, Inc.$44,034,909
Research focus
Acquired Immunodeficiency SyndromeClinical TrialsCollaborationsCommunitiesContractsDevicesExtramural ActivitiesHepatitis C VirusInvestigational New Drug ApplicationInvestigator-Initiated ResearchLicensureMycobacterium TuberculosisNational Institute Of Allergy And Infectious DiseaseNovel TherapeuticsPre-ClinicalPrivate SectorProduct DevelopmentRepositoryResearch Clinical TestingResearch StudyResourcesServicesTherapeutic DevelopmentUnited States Food And Drug Administration
Grant awards (4)
Testing of a Novel Inhaled Clofazimine (CFZ) Dry Powder Formulation in a Mouse Model of Mycobacterium tuberculosis$108,436
N01 · FY2025 · AI · contact PI
Testing of a Novel Inhaled Clofazimine (CFZ) Dry Powder Formulation in a Mouse Model of Mycobacterium tuberculosis$680,009
N01 · FY2023 · AI · contact PI
Testing of Standard Drugs for Mycobacterium Tuberculosis (MTB) in Animal Models for MTB$372,598
N01 · FY2021 · AI · contact PI
Preclinical Services for HIV Therapeutics: QA/QC Plan and Task Order Initiation Meeting$3,037
N01 · FY2021 · AI · contact PI